Northwestern Medicine is looking for recruits for trials of a potential COVID-19 vaccine.
CHICAGO (CBS Chicago/CBS News) — Northwestern Medicine is looking for recruits for trials for a potential COVID-19 vaccine. Northwestern University Feinberg School of Medicine is sponsoring the research and has set up a registry for potential participants for the trials of vaccines and other studies. The first study, set for August, will be a Phase III trial for a vaccine being developed by Oxford University’s Jenner Institute, in conjunction with pharmaceutical giant AstraZeneca. “We want to recruit participants in the Chicago area who are at risk for exposure to COVID-19 and who are potentially interested in participating in different studies for prevention of the infection,” Dr. Karen Krueger, the principal investigator of the registry, said in a news release. Participants in the registry will be contacted after a study on their health profile is complete. The goal is to recruit 5,000 people. Northwestern is looking for at-risk people 18 or older who work in a job that puts them at high risk.
